Credit Suisse’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Credit Suisse’s Portfolio LABD Stock Details LABD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,307	Closed	-$330K	–	4448
2020 Q4	$330K	Buy	+1,307	New	+$498K	﹤0.01%	3945
2018 Q2	–	Sell	-67	Closed	-$492K	–	4067
2018 Q1	$492K	Buy	+67	New	+$466K	﹤0.01%	3373
2017 Q3	–	Sell	-75	Closed	-$1.03M	–	4226
2017 Q2	$1.03M	Hold	75	–	–	﹤0.01%	2672
2017 Q1	$1.57M	Buy	+75	New	+$1.85M	﹤0.01%	2530

Other funds holding LABD

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SFS

Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Credit Suisse's LABD Position: Q1 2021 in Review

Credit Suisse sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q1 2021, closing a stake of 1,307 shares — an estimated $330K sold.

Credit Suisse first reported a position in LABD in Q1 2017 and held it in 4 quarters. The position peaked at $1.57M in Q1 2017. 12 funds tracked by Wall St. Rank hold LABD as of Q1 2021.

Credit Suisse reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q1 2021 after selling out during the quarter.
Credit Suisse sold 1,307 Direxion Daily S&P Biotech Bear 3X ETF shares in Q1 2021, an estimated $330K.
Credit Suisse first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q1 2017 and held it in 4 quarters.
Credit Suisse's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $1.57M in Q1 2017.
12 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q1 2021.

Based on Credit Suisse's 13F filing for Q1 2021, filed 14 May 2021.